The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1384
February 20, 2012
View Complete Issue         Table of Contents 2019 
Zolpidem Oral Spray (Zolpimist) for Insomnia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Zolpidem Oral Spray (Zolpimist) for Insomnia
February 20, 2012 (Issue: 1384)
Zolpidem oral spray (Zolpimist – NovaDel/ECR), a new formulation of the oral hypnotic zolpidem tartrate (Ambien, and others), has been approved by the FDA for short-term treatment of insomnia characterized by difficulty falling...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Zolpidem Oral Spray (Zolpimist) for Insomnia
Article code: 1384b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.